Welcome to our dedicated page for DT Cloud Acquisition news (Ticker: DYCQ), a resource for investors and traders seeking the latest updates and insights on DT Cloud Acquisition stock.
DT Cloud Acquisition Corporation (Nasdaq: DYCQ) is a special purpose acquisition company (SPAC) whose public disclosures generate a steady flow of corporate and regulatory news. As a blank check company formed to complete a business combination, DT Cloud’s news coverage centers on its capital markets activity, proposed transactions and interactions with shareholders and regulators.
News items for DYCQ include announcements related to its initial public offering of units on Nasdaq, the commencement of separate trading for its ordinary shares (DYCQ) and rights (DYCQR), and subsequent developments in its search for a business combination partner. A major focus of recent news has been the definitive business combination agreement with Maius Pharmaceutical Co., Ltd., under which Maius is expected to become a wholly owned subsidiary of a newly formed holding company, Maius Pharmaceutical Group Co., Ltd. (Pubco), whose securities are intended to be listed on Nasdaq.
Investors following DYCQ news will also see updates on extraordinary general meetings (EGMs), including meeting cancellations, postponements and changes to redemption deadlines, as well as filings of definitive proxy statements and proxy supplements with the U.S. Securities and Exchange Commission. Additional coverage includes information about subscription agreements and private placements related to financing efforts for the proposed transaction with Maius.
Regulatory and listing developments are another key news category. DT Cloud has reported Nasdaq notices regarding continued listing requirements, including minimum market value of publicly held shares and determinations affecting its Nasdaq Global Market listing status. For market participants tracking SPAC activity and the progression of the DT Cloud–Maius transaction, this news page provides a centralized view of press releases and related updates tied to DYCQ and its associated securities.
DT Cloud Acquisition Corporation (Nasdaq: DYCQU) has announced changes to its upcoming Extraordinary General Meeting (EGM) schedule. The EGM has been postponed from May 21, 2025, to May 23, 2025, at 10:00 a.m. Eastern Time. Additionally, the redemption right deadline has been extended to May 21, 2025, at 5:00 p.m. Eastern Time.
The record date remains April 30, 2025, and no changes have been made to the proposals for shareholder voting. Shareholders who have already submitted their proxies and do not wish to change their votes need not take any action. The company has filed its definitive proxy statement with the SEC on May 6, 2025, with additional supplements filed on May 19, 2025.
DT Cloud Acquisition (Nasdaq: DYCQU) has announced changes to its upcoming Extraordinary General Meeting (EGM) schedule. The meeting, originally planned for April 18, 2025, at 10:00 a.m. Eastern Time, has been rescheduled to April 23, 2025, at the same time.
Key updates include:
- New redemption right deadline: April 21, 2025, at 5:00 p.m. Eastern Time
- Record date remains unchanged: March 31, 2025
- No modifications to shareholder voting proposals
The SPAC has filed a definitive proxy statement with the SEC on April 3, 2025, followed by additional proxy supplements on April 3, 4, and 9, 2025. Previously submitted proxy votes remain valid unless shareholders wish to change their vote. All relevant documents are available through the SEC website.
DT Cloud Acquisition (Nasdaq: DYCQU, DYCQ, DYCQR) has announced the cancellation of its extraordinary general meeting (EGM) that was scheduled for February 21, 2025, at 10:00 a.m. Eastern Time. The SPAC has also withdrawn all proposals that were outlined in its definitive proxy statement filed with the SEC on January 27, 2025, including its subsequent amendments from February 4, 14, and 19, 2025.
DT Cloud Acquisition (Nasdaq: DYCQU) has announced changes to its upcoming Extraordinary General Meeting (EGM) schedule. The meeting, originally set for February 18, 2025, has been rescheduled to February 21, 2025 at 10:00 a.m. Eastern Time. Additionally, the redemption right deadline has been moved to February 19, 2025, at 5:00 p.m. Eastern Time.
The SPAC has filed a proxy supplement on February 14, 2025, with an amendment on February 19, 2025, proposing an increase in the monthly extension fee to $0.022 per outstanding Public Share under Proposal 1 of the EGM.
DT Cloud Acquisition (Nasdaq: DYCQU) has announced a business combination agreement with Maius Pharmaceutical, a biopharmaceutical R&D company. The transaction values Maius at $250 million in equity value. Upon closing, Maius will become a wholly-owned subsidiary of Maius Pharmaceutical Group, with securities listed on Nasdaq. Maius focuses on developing innovative formulations and targeted small-molecule chemical drugs in three areas: anticancer drugs, autoimmune medication, and anti-infectives. The transaction is expected to close in the first half of 2025, subject to regulatory and shareholder approvals.
DT Cloud Acquisition (Nasdaq: DYCQU, DYCQ, DYCQR) has announced a non-binding letter of intent (LOI) for a business combination with Shanghai Maius Pharmaceutical Technology Co., Founded in 2015, Shanghai Maius is a biopharmaceutical R&D company specializing in innovative formulations and targeted small-molecule chemical drugs.
The proposed deal would involve DT Cloud acquiring 100% of Shanghai Maius's equity or all of its business, with the final structure to be determined. The combined public company would adopt Shanghai Maius's branding. A definitive agreement is expected in Q4 2024, subject to board and shareholder approvals, regulatory clearances, and other conditions.
Summary not available.
Summary not available.
Summary not available.
FAQ
What is the current stock price of DT Cloud Acquisition (DYCQ)?
What is the market cap of DT Cloud Acquisition (DYCQ)?
